Putnam Focused U.S. Research ETF
PFRX · ETF
About PFRX
- Issuer
- Putnam
- Expense ratio
- 0.35%
- Assets under management
- $0
- Inception
- Sep 28, 2026
- Asset class
- Equity
- Website
- franklintempleton.com
PFRX key statistics
- Average volume
- 46.23K
- Volume
- 12.95K
- Open price
- $32.80
- High today
- $32.94
- Low today
- $32.77
- 52 Week high
- $33.87
- 52 Week low
- $32.80
Putnam Focused U.S. Research ETF (PFRX) at a glance
As of Oct 23, 2026, Putnam Focused U.S. Research ETF (PFRX) shares are priced at $32.80.
Today the fund has traded between $32.77 and $32.94. The current price is 0.1% above the day's low and 0.4% below its high.
Volume so far is 12.95K shares, below the average of 46.23K shares a day.
Over the past year Putnam Focused U.S. Research ETF has ranged from $32.80 to $33.87, and now sits 0% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.